FDA Drug recall D-0375-2022
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dis…
- FDA Drug
- Class I
- terminated
- Published 2022-01-19
On 2022-01-19 the FDA classified a Class I recall of Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dis… by Taro Pharmaceuticals U, citing microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0375-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-12-15 |
| Published | 2022-01-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Taro Pharmaceuticals U |
| Distribution | US |
Product
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
Reason
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Identifiers
| ndc | 51672-1294-1 |
|---|---|
| ndc | 51672-1294-2 |
| ndc | 51672-1294-3 |
| ndc | 51672-1258-1 |
| ndc | 51672-1258-2 |
| ndc | 51672-1258-6 |
| ndc | 51672-1258-3 |
| ndc | 51672-1259-1 |
| ndc | 51672-1259-2 |
| ndc | 51672-1259-6 |
| ndc | 51672-1259-3 |
| code_info | Lot# AC13786, exp. date DEC 2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0375-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.